Dev Jr A, Vachher M, Prasad C
Bioengineered. 2023; 14(1):2251696.
PMID: 37655825
PMC: 10478749.
DOI: 10.1080/21655979.2023.2251696.
Choi S, Cho N, Kim K
Exp Mol Med. 2023; 55(4):755-766.
PMID: 37009804
PMC: 10167241.
DOI: 10.1038/s12276-023-00981-7.
Shen Q, Wang H, Zhang L
Cancer Manag Res. 2023; 15:217-231.
PMID: 36873253
PMC: 9974772.
DOI: 10.2147/CMAR.S387781.
Tanaka K, Matsumaru D, Suzuki K, Yamada G, Miyagawa S
Dev Growth Differ. 2023; 65(2):132-140.
PMID: 36680528
PMC: 11520970.
DOI: 10.1111/dgd.12840.
Pecorari R, Bernassola F, Melino G, Candi E
Biochem J. 2022; 479(12):1375-1392.
PMID: 35748701
PMC: 9250260.
DOI: 10.1042/BCJ20210737.
Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry.
Guven-Maiorov E, Sakakibara N, Ponnamperuma R, Dong K, Matar H, King K
Mol Carcinog. 2022; 61(7):629-642.
PMID: 35560453
PMC: 9949960.
DOI: 10.1002/mc.23405.
MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.
Jorgensen B, Ro S
Int J Mol Sci. 2022; 23(4).
PMID: 35216281
PMC: 8876324.
DOI: 10.3390/ijms23042166.
Hydrochlorothiazide Use and Risk of Nonmelanoma Skin Cancers: A Biological Plausibility Study.
Bigagli E, Cinci L, DAmbrosio M, Nardini P, Portelli F, Colucci R
Oxid Med Cell Longev. 2021; 2021:6655542.
PMID: 34434485
PMC: 8382532.
DOI: 10.1155/2021/6655542.
Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas.
Choe J, Mazambani S, Kim T, Kim J
Cells. 2021; 10(3).
PMID: 33803326
PMC: 8000417.
DOI: 10.3390/cells10030606.
Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
Fu H, Zhang Y, Chen J, Zhou B, Chen G, Chen P
Mol Ther Oncolytics. 2020; 18:126-136.
PMID: 32671188
PMC: 7338996.
DOI: 10.1016/j.omto.2020.06.005.
Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li M, Fan L, Han D, Yu Z, Ma J, Liu Y
J Clin Invest. 2020; 130(8):4301-4319.
PMID: 32396532
PMC: 7410060.
DOI: 10.1172/JCI134930.
p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas.
Hsieh M, Choe J, Gadhvi J, Kim Y, Arguez M, Palmer M
Cell Rep. 2019; 28(7):1860-1878.e9.
PMID: 31412252
PMC: 7048935.
DOI: 10.1016/j.celrep.2019.07.027.
YAP, ΔNp63, and β-Catenin Signaling Pathways Are Involved in the Modulation of Corneal Epithelial Stem Cell Phenotype Induced by Substrate Stiffness.
Gouveia R, Vajda F, Wibowo J, Figueiredo F, Connon C
Cells. 2019; 8(4).
PMID: 31013745
PMC: 6523807.
DOI: 10.3390/cells8040347.
C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin.
Katoh I, Maehata Y, Moriishi K, Hata R, Kurata S
Neoplasia. 2019; 21(5):494-503.
PMID: 30986748
PMC: 6462804.
DOI: 10.1016/j.neo.2019.03.010.
ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment.
Gatti V, Fierro C, Annicchiarico-Petruzzelli M, Melino G, Peschiaroli A
Mol Oncol. 2019; 13(5):981-1001.
PMID: 30845357
PMC: 6487733.
DOI: 10.1002/1878-0261.12473.
Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X, Zheng Y, Wang Z, Dong Y, Chen W, Li J
Oncol Rep. 2018; 39(6):2584-2594.
PMID: 29620248
PMC: 5983926.
DOI: 10.3892/or.2018.6335.
PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.
Zhao H, Li D, Zhang B, Qi Y, Diao Y, Zhen Y
Molecules. 2017; 22(12).
PMID: 29261144
PMC: 6149800.
DOI: 10.3390/molecules22122277.
Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z, Xie N, Hu J, Yu P, Wang C, Hu X
Oncotarget. 2017; 8(13):21954-21973.
PMID: 28423539
PMC: 5400637.
DOI: 10.18632/oncotarget.15752.
Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.
Mezzomo L, Pesce F, Marcal J, Haag T, Ferreira N, Lima J
Endocr Pathol. 2017; 28(1):13-21.
PMID: 28078618
DOI: 10.1007/s12022-016-9463-2.
ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.
Stacy A, Craig M, Sakaram S, Kadakia M
Oncotarget. 2016; 8(2):2114-2129.
PMID: 27924063
PMC: 5356785.
DOI: 10.18632/oncotarget.13797.